A Trial of AK117 (Anti-CD47 Antibody) in Patients With Acute Myeloid Leukemia

NCT04980885 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: AK117
DRUG: Azacitidine

Sponsor

Akeso